Indefinite Delivery Contract W81K0224D0006

Award Date 9/6/24
Last Date to Order 9/5/29
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of the Army Medical Command awarded a single award indefinite delivery contract to Seoul Clinical Laboratories to provide clinical laboratory testing services for COVID-19 at Brian D. Allgood Army Community Hospital in South Korea. Two firm fixed price delivery orders were issued against the contract vehicle, the first for $6.7 million to support testing needs from October 2020 through September 2021, and the second for $3.1 million to support testing from October 2021 through...
The Department of the Army Medical Command awarded a single award indefinite delivery contract to Seoul Clinical Laboratories to provide COVID-19 clinical laboratory testing services. Under the contract's initial $4.1M firm fixed price delivery order, Seoul Clinical Laboratories will conduct COVID-19 testing for patients of the Brian D. Allgood Army Community Hospital in South Korea from May 15, 2020 through September 30, 2020. The contract supports the Army Medical Command's mission to...
The Department of the Army Medical Command awarded a single award, firm fixed price delivery order contract valued at $1.4 million to Seoul Clinical Laboratories. The contract provides clinical laboratory testing services for COVID-19 at the Brian D. Allgood Army Community Hospital in South Korea. Performance will take place over a one year period from April 2020 through April 2021. The funding supports testing needs under the Coronavirus COVID-19 national interest action code. The delivery...
The federal contract IDV award is for clinical laboratory testing services to support U.S. military healthcare operations in South Korea. The prime contractor is Seoul Clinical Laboratories, a for-profit research institute in South Korea that provides a wide range of medical laboratory services, including COVID-19 testing, to U.S. Department of Defense (DoD) agencies. The contract is a single-award indefinite delivery vehicle (IDV) valued at $547,695.69 awarded by the Defense Health Agency, with...
The U.S. Department of the Air Force, Pacific Air Forces (PACAF), awarded a multiple-award Blanket Purchase Agreement (BPA) contract to Seoul Clinical Laboratories, a for-profit research institute located in South Korea. The $250,000 BPA provides clinical laboratory testing and diagnostic services, including COVID-19 testing, general blood work, and pathology testing, to support U.S. military healthcare operations in South Korea. The contract has a period of performance through February 2026 and...
The U.S. Defense Health Agency (DHA) awarded a single-award indefinite delivery contract to STG Korea Inc., a for-profit organization, to provide clinical laboratory testing services for COVID-19 at the Brian D. Allgood Army Community Hospital in South Korea. The contract has a ceiling value of $13,000,000 and a period of performance through March 31, 2027. Under this IDV, DHA has issued firm fixed price delivery orders to STG Korea Inc. totaling $850,310 from June 2022 through March 2023, and...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Army Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch, a for-profit medical equipment manufacturer and supplier. The $3,438,000 single-award contract, awarded on November 1, 2020, aims to provide COVID-19 anti SARS-CoV-2 test reagents to the Brian D. Allgood Army Community Hospital in South Korea through September 30, 2023. An initial $10,000 firm fixed price delivery order was placed on...
The Defense Health Agency (DHA) has awarded Namu Med Sales Division, a for-profit South Korean company, an Indefinite Delivery Contract (IDC) with a ceiling value of $1,073,259.72 to provide biochemical antibiotics susceptibility testing reagents and supplies for military medical facilities and research programs in South Korea, including the Brian Allgood Army Community Hospital. This single-award IDC, which runs through September 2027, allows the DHA to issue task orders for these specialized...
The U.S. Army Medical Command (MEDCOM) awarded a single-award Indefinite Delivery Contract (IDC) to Koam Partners Co., Ltd., a for-profit international organization, to provide respiratory and gastrointestinal panel test kits. The $1,093,520 IDC has a 5-year ordering period ending September 30, 2024. Under this IDC, MEDCOM has issued multiple firm fixed-price delivery orders to Koam Partners for the supply of respiratory and gastrointestinal panel test kits, totaling over $154,000 to date. The...
This federal contract IDV award, with the ID W81K0219D0004, is a single-award indefinite delivery contract held by the prime contractor BMI, a for-profit organization based in South Korea. The contract, valued at up to $1,282,010.00, was awarded on June 1, 2019 by the U.S. Army Medical Command, a component of the Defense Health Agency. The purpose of this contract is to provide Beckman Coulter reagents, medical equipment, and related supplies to support laboratory operations and patient care...
  • W81K0224D0006
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of the Army Medical Command (MEDCOM) awarded a single-award Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract to Seoul Clinical Laboratories, a for-profit research institute located in South Korea, to provide clinical laboratory testing services for the Brian D. Allgood Army Community Hospital (BDAACH) in Korea. The contract has a base period of one year from September 2024 to September 2025, with up to four one-year option periods, for a total potential period of performance through September 2029. The contract ceiling value is $298,717.40.

The contracted services include testing of specimens, communication of results, and provision of related services such as supplies, labor, customer service, and reporting. The scope encompasses a wide range of clinical and anatomic testing, including but not limited to, pain management panels, treponema pallidum particle agglutination, hepatitis B surface antibody neutralization, renal biopsy, and muscle biopsy testing. The contract supports the ongoing healthcare requirements of U.S. military personnel stationed in South Korea, leveraging Seoul Clinical Laboratories' extensive experience and capabilities as a mega-reference laboratory serving the region.

Generated 11/26/24, 9:05 AM